Literature DB >> 3789777

Erythematosquamous skin lesions in hereditary lactate dehydrogenase M-subunit deficiency.

K Yoshikuni, H Tagami, M Yamada, K Sudo, T Kanno.   

Abstract

Peculiar erythematosquamous lesions were observed in two adult patients in Japan with hereditary lactate dehydrogenase M-subunit deficiency. Although these patients showed excessive fatigue and myoglobulinuria after extended exercise, they were usually asymptomatic. However, nonpruritic follicular papules or erythematous patches with scaly edges were present on the extensor surfaces of the extremities of these patients since childhood, showing some improvement after puberty. There were also erythematous patches on the weight-bearing areas of their soles. These patches showed exacerbation and a tendency toward peripheral spreading in summer. These skin lesions provide an important clue in the detection of this genetic enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789777

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

1.  Lactate dehydrogenase and glycerol-3-phosphate dehydrogenase cooperatively regulate growth and carbohydrate metabolism during Drosophila melanogaster larval development.

Authors:  Hongde Li; Madhulika Rai; Kasun Buddika; Maria C Sterrett; Arthur Luhur; Nader H Mahmoudzadeh; Cole R Julick; Rose C Pletcher; Geetanjali Chawla; Chelsea J Gosney; Anna K Burton; Jonathan A Karty; Kristi L Montooth; Nicholas S Sokol; Jason M Tennessen
Journal:  Development       Date:  2019-09-12       Impact factor: 6.868

2.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

3.  Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers.

Authors:  Nicola J Brown; Sue E Higham; Branko Perunovic; Mohammad Arafa; Sabapathy Balasubramanian; Ishtiaq Rehman
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

5.  Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Authors:  Gema Ariceta; Kelly Barrios; Bob D Brown; Bernd Hoppe; Ralf Rosskamp; Craig B Langman
Journal:  Kidney Int Rep       Date:  2021-02-03

Review 6.  Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria.

Authors:  Thomas A Forbes; Bob D Brown; Chengjung Lai
Journal:  Br J Clin Pharmacol       Date:  2021-06-11       Impact factor: 3.716

7.  Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.

Authors:  Kyle D Wood; Ross P Holmes; David Erbe; Abigail Liebow; Sonia Fargue; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

8.  Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature.

Authors:  Martina Maurelli; Paolo Gisondi; Chiara Colato; Giampiero Girolomoni
Journal:  Case Rep Dermatol       Date:  2021-06-10

9.  Identification of the first highly selective inhibitor of human lactate dehydrogenase B.

Authors:  Sachio Shibata; Satoshi Sogabe; Masanori Miwa; Takuya Fujimoto; Nobuyuki Takakura; Akihiko Naotsuka; Shuji Kitamura; Tomohiro Kawamoto; Tomoyoshi Soga
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.